EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Electrochemotherapy for Recurrence and/or Metastatic Skin Cancers: A Prospective Case Series in Iran

Seyed Mojtaba YazdanParast iD, Sepideh Mansouri, Farshid Rostami Pouria, Navid Manoochehri, Kosar Namakin, Alvand Naserghandi, Seyed Rouhollah Miri, Habibollah Mahmoodzadeh, Omid Nabavian iD, Shirin Zaresharifi, Mohammad Abdolahad iD

Technology in Cancer Research & Treatment · 2025

DOI: 10.1177/15330338251338635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Seyed Mojtaba YazdanParast und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nano Electronic Center of Excellence, Nano Bio Electronic Devices Lab, School of Electrical and Computer Engineering, University of Tehran, Tehran, I…. Hauptthemen laut MEDLINE: Electrochemotherapy, Skin Neoplasms, Neoplasm Recurrence, Local, Basal Cell Carcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to investigate the efficacy of electrochemotherapy on the three common types of skin cancer, including basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), and melanoma.

Methods

26 patients with skin cancer were recruited from single cancer treatment centers from 2022 to 2024. Electrochemotherapy (ECT) was performed to treat the cancerous nodules; all nodules in a patient with multiple lesions were treated. However the biggest lesions were always pointed out (according to European Standard Operating Procedures on Electrochemotherapy protocol) and their clinical response and adverse effects were evaluated during the study. Results totally, 104 nodules of 26 patients were assessed. Clinical complete response was achieved in 53 lesions, while partial response was observed in 51 lesions after first month of treatment. The most common adverse effect was pain which was in 65% of cases.

Conclusion

BCC shows a notably higher clinical complete response rate. Because the research was conducted at a single center and given the novelty of this treatment in Iran, the number of patients included in the study was limited. Electrochemotherapy (ECT) has shown significant clinical effectiveness for superficial tumors, especially for patients who have health issues related to standard therapies or who are resistant to conventional treatments. It is generally well-tolerated, with side effects predominantly consisting of temporary pain. Ongoing research aims to expand its use in deep-seated tumors that are resistant to conventional therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectrochemotherapySkin NeoplasmsNeoplasm Recurrence, LocalBasal Cell CarcinomaCarcinoma, Squamous CellMelanomaHumansMaleFemaleMiddle AgedAgedIranProspective StudiesTreatment OutcomeAdultAged, 80 and overNeoplasm Metastasis

Stichwörter der Autor:innen

adverse effectselectrochemotherapyelectroporationresponse rateskin cancer

Autor:innen und Institutionen

  • Nano Electronic Center of Excellence, Nano Bio Electronic Devices Lab, School of Electrical and Computer Engineering, University of Tehran, Tehran, Iran.
  • UT and TUMS Cancer Electronics Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Radiation Oncology Research Center (RORC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of General Surgery, Tehran University of Medical Sciences, Cancer Institute, Tehran, Iran.
  • Department of Anesthesiology and Intensive Care, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Seyed Mojtaba YazdanParast, Omid Nabavian, Mohammad Abdolahad

Zitieren

APA

YazdanParast, S. M., Mansouri, S., Rostami Pouria, F., Manoochehri, N., Namakin, K., Naserghandi, A., Miri, S. R., Mahmoodzadeh, H., Nabavian, O., Zaresharifi, S., & Abdolahad, M. (2025). Electrochemotherapy for Recurrence and/or Metastatic Skin Cancers: A Prospective Case Series in Iran. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251338635

Vancouver

YazdanParast SM, Mansouri S, Rostami Pouria F, Manoochehri N, Namakin K, Naserghandi A, et al. Electrochemotherapy for Recurrence and/or Metastatic Skin Cancers: A Prospective Case Series in Iran. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251338635

BibTeX
@article{YazdanParast2025,
  author = {YazdanParast, Seyed Mojtaba and Mansouri, Sepideh and Rostami Pouria, Farshid and Manoochehri, Navid and Namakin, Kosar and Naserghandi, Alvand and Miri, Seyed Rouhollah and Mahmoodzadeh, Habibollah and Nabavian, Omid and Zaresharifi, Shirin and Abdolahad, Mohammad},
  title = {Electrochemotherapy for Recurrence and/or Metastatic Skin Cancers: A Prospective Case Series in Iran},
  journal = {Technology in Cancer Research & Treatment},
  year = {2025},
  doi = {10.1177/15330338251338635}
}
Kostenlos starten →